HUT52112A - Process for producing 11beta-4,9,15-estratriene derivatives and pharmaceutical compositions comprising such compounds - Google Patents

Process for producing 11beta-4,9,15-estratriene derivatives and pharmaceutical compositions comprising such compounds

Info

Publication number
HUT52112A
HUT52112A HU884582A HU458288A HUT52112A HU T52112 A HUT52112 A HU T52112A HU 884582 A HU884582 A HU 884582A HU 458288 A HU458288 A HU 458288A HU T52112 A HUT52112 A HU T52112A
Authority
HU
Hungary
Prior art keywords
implies
pct
carbon atoms
hydrogen atom
compounds
Prior art date
Application number
HU884582A
Other languages
English (en)
Other versions
HU203764B (en
Inventor
Eshkhard Ottow
Helmut Hofmeister
Stefan Scholz
Guenter Neef
Walter Elger
Sybille Beier
Krzysztof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HUT52112A publication Critical patent/HUT52112A/hu
Publication of HU203764B publication Critical patent/HU203764B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU884582A 1987-07-16 1988-07-15 Process for producing 11-beta-4,9,15-estratiene derivatives and pharamceutical compositions containing them HU203764B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873723788 DE3723788A1 (de) 1987-07-16 1987-07-16 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
HUT52112A true HUT52112A (en) 1990-06-28
HU203764B HU203764B (en) 1991-09-30

Family

ID=6331846

Family Applications (1)

Application Number Title Priority Date Filing Date
HU884582A HU203764B (en) 1987-07-16 1988-07-15 Process for producing 11-beta-4,9,15-estratiene derivatives and pharamceutical compositions containing them

Country Status (12)

Country Link
US (1) US5132299A (hu)
EP (1) EP0299913B1 (hu)
JP (1) JP2792876B2 (hu)
AT (1) ATE87631T1 (hu)
CA (1) CA1320946C (hu)
DD (1) DD281809A5 (hu)
DE (2) DE3723788A1 (hu)
DK (1) DK43189A (hu)
ES (1) ES2054859T3 (hu)
FI (1) FI94349C (hu)
HU (1) HU203764B (hu)
WO (1) WO1989000578A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3917274A1 (de) * 1989-05-24 1990-11-29 Schering Ag 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
EP0411733B1 (de) * 1989-08-04 1998-10-21 Schering Aktiengesellschaft 11 Beta-Aryl-gona-4,9-dien-3-one
DE4042004A1 (de) * 1990-12-22 1992-06-25 Schering Ag 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US5767113A (en) * 1995-05-10 1998-06-16 The Salk Institute For Biological Studies Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
DE102004059880A1 (de) * 2004-12-10 2006-06-14 Grünenthal GmbH Stabiles, hormonhaltiges (Zwischen-)Produkt
WO2011150209A1 (en) 2010-05-26 2011-12-01 Corcept Therapeutics, Inc. Treatment of muscular dystrophy
WO2016140867A1 (en) 2015-03-02 2016-09-09 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonist and somatostatin analogues to treat acth-secreting tumors
CA2978960C (en) 2015-03-30 2023-05-02 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
ES2865334T3 (es) 2015-08-13 2021-10-15 Corcept Therapeutics Inc Método de diagnóstico diferencial de síndrome de Cushing dependiente de ACTH
SG11201806101SA (en) 2016-01-19 2018-08-30 Corcept Therapeutics Inc Differential diagnosis of ectopic cushing's syndrome
MX2019011543A (es) 2017-03-31 2019-12-16 Corcept Therapeutics Inc Moduladores del receptor de glucocorticoides para el tratamiento de cancer cervical.
CA3065555A1 (en) 2017-06-20 2018-12-27 Corcept Therapeutics, Inc. Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
EP3713086A1 (de) 2019-03-18 2020-09-23 Siemens Aktiengesellschaft Schutzschaltung für einen halbleiterschalter
JP2024500748A (ja) 2020-12-18 2024-01-10 インスティル バイオ （ユーケイ） リミテッド 腫瘍浸潤リンパ球の処理

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2530817A (en) * 1948-05-19 1950-11-21 Univ Pennsylvania 13-monomethyl steroids
US2940968A (en) * 1958-10-01 1960-06-14 Merck & Co Inc Dimethylated steroids and processes for producing same
CH558346A (de) * 1971-06-17 1975-01-31 Sandoz Ag Verfahren zur herstellung neuer 3-oximino-17(alpha)-propadienyl-substituierter steroide.
DE3042529A1 (de) * 1980-11-07 1982-06-24 Schering Ag, 1000 Berlin Und 4619 Bergkamen 11-methylen- (delta)(pfeil hoch)1(pfeil hoch)(pfeil hoch)5(pfeil hoch) -steroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
EP0116974B1 (de) * 1983-02-18 1986-10-29 Schering Aktiengesellschaft 11-Beta-Aryl-Estradiene, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
FI94349C (fi) 1995-08-25
FI94349B (fi) 1995-05-15
FI900217A0 (fi) 1990-01-15
ES2054859T3 (es) 1994-08-16
JP2792876B2 (ja) 1998-09-03
DK43189D0 (da) 1989-01-31
DE3723788A1 (de) 1989-01-26
JPH03500642A (ja) 1991-02-14
DD281809A5 (de) 1990-08-22
EP0299913A1 (de) 1989-01-18
US5132299A (en) 1992-07-21
CA1320946C (en) 1993-08-03
EP0299913B1 (de) 1993-03-31
ATE87631T1 (de) 1993-04-15
WO1989000578A1 (en) 1989-01-26
HU203764B (en) 1991-09-30
DE3879787D1 (de) 1993-05-06
DK43189A (da) 1989-01-31

Similar Documents

Publication Publication Date Title
HUT52112A (en) Process for producing 11beta-4,9,15-estratriene derivatives and pharmaceutical compositions comprising such compounds
IE820211L (en) Process for preparing 2-penem compounds
HUT44272A (en) Process for production of 11-beta-/4-isoprophenile-phenil/-oestrin-4,9-diens and medical compositions containing them
NZ508918A (en) 2-(Purin-9-YL)-tetrahydrofuran-3,4-diol derivatives useful for the treatment of inflammation
NZ240050A (en) Substituted piperazine derivatives; pharmaceutical compositions and preparatory processes
ES8405398A1 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
DE3264172D1 (en) N-2-hydroxypropyl piperidines and process for preparing the same
DE3372964D1 (en) Composition active against mites, whitefly and thrips, pharmaceutical composition, and new benzoylureau compounds
ES8401068A1 (es) Procedimiento para la preparacion de derivados de corinanteina, asi como de sus sales de adicion acida fisiologicamente inocuas.
IE900509L (en) 2-amino-7-hydroxytetralin carboxyalkyl ethers
IL82137A (en) Method for defoliating plants by means of compositions containing thiadiazolylureas
HUT37767A (en) Process for preparing isoxazole derivatives further pharmaceutical compositions containing such compounds as active substances
ES8400743A1 (es) "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona".
ES8304571A1 (es) "procedimiento para la preparacion de nuevas 1,4,9,10-tetrahidro-pirazolo (4,3-e)pirido (3,2-b) (1,4)diazepin-10-onas".
DE3564426D1 (en) Polyprenyl compound, process of producing it and pharmaceutical use
JPS57181051A (en) Substituted 2,4-dialkoxybenzene sulfohalides, manufacture and use
DE3462131D1 (en) Process for the preparation of alpha-delta-diethylenic carbonyl compounds
JPS6463517A (en) Antianxiety composition
ATE18223T1 (de) Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3160549D1 (en) Process for the preparation of chlorophenols
ES478072A1 (es) Un procedimiento de preparacion de 2-metoxi-benzamidas.

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee
HNF4 Restoration of lapsed final prot.
HMM4 Cancellation of final prot. due to non-payment of fee